Telemetry Investments, L.L.C. Mannkind Corp Transaction History

Telemetry Investments, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 17, 2022	BUY	$2.99 - $4.35 $119,600 - $174,000	40,000 Added 80.0%	90,000 $278,000
Q2 2022 Aug 15, 2022	BUY	$2.67 - $4.77 $133,500 - $238,499	50,000 New	50,000 $190,000
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.45 $635,399 - $959,259	-176,011 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.14 - $6.14 $552,674 - $1.08 Million	176,011 New	176,011 $690,000

248

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.44B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.